Richard Vincent

Chief Financial Officer

Richard Vincent currently serves as chief financial officer of Zavante Therapeutics. Vincent has more than 25 years of experience in strategic and operational planning and finance for both early-stage private companies and commercialized public companies across multiple industries.  He has held senior management positions at Suneva Medical, Genoa Pharmaceuticals, Meritage Pharma, Sorrento Therapeutics, Elevation Pharmaceuticals, Verus Pharmaceuticals, Women First HealthCare, Elan Pharmaceuticals, Phase Metrics and Deloitte & Touche LLP, where he specialized in emerging growth and publicly-reporting companies. For the past 20 years, Vincent’s experience includes raising over $600 million through venture capital, major commercial banks and institutions, and public offering proceeds for high growth pharmaceutical and technology-based companies, as well as participating in a number of acquisitions, divestitures and license activities valued at over $2 billion. Vincent was named 2014 public company CFO of the Year in San Diego by the San Diego Business Journal. He is a certified public accountant in California and holds a bachelor’s degree in business from San Diego State University.